Abstract:The non-classical HLA-Ib molecule, HLA-E share several peptide sequence similarities with the heavy chains of classical HLA class Ia (-B and -C) molecules. Therefore, the antibodies to HLA-E, that recognize shared sequences, may bind to HLA-Ia alleles. This hypothesis is tested by examining the affinity of HLA-E monoclonal antibodies (HLA-E-MAbs) to HLA-Ia molecules and by inhibiting the antibody binding to both HLA-E and HLA-Ia with the shared peptide sequence(s). Single recombinant HLA molecule-coated beads are used for antibody binding. The antibody binding is evaluated by measuring mean fluorescence index [MFI] with Luminex multiplex flow-cytometric technology. The peptide-inhibition experiments are carried out with synthetic shared peptides, most prevalent to HLA-E and HLA-Ia alleles. The number of HLA-Ia alleles recognized by the HLA-E-MAbs varies with the density of the antigen (quantity of antigen-coated beads) and dilution of MAb. Binding of HLA-E-MAbs to beta2 microglobulin (beta(2)m)-free HLA-Ia antigens confirms the location of the epitopes on the heavy chain (HC) of the antigens. Strikingly, the nature of alleles of HLA-Ia recognized by different HLA-E-MAbs is identical. The binding of HLA-E-MAbs to the HLA-Ia is inhibited dosimetrically by the adjacent peptides, (115)QFAYDGKDY(123) and (137)DTAAQI(142), but not by (126)LNEDLRSWTA(135), another closer shared peptide sequence. The inhibitory peptide sequences in HLA-E are at the alpha2-helix terminal facing beta(2)m. The HLA-Ia alleles recognized by HLA-E-MAb (e.g., MEM-E/02) are similar to those recognized by the natural anti-HLA antibodies found in the sera of healthy non-alloimmunized males. This study postulates that some, if not all, of the natural HLA-Ia antibodies seen in healthy males could be anti-HLA-E antibodies cross-reacting with HLA-Ia alleles.

HLA-E Allelic Variants: CORRELATING DIFFERENTIAL EXPRESSION, PEPTIDE AFFINITIES, CRYSTAL STRUCTURES, AND THERMAL STABILITIES

HLA-E Allelic Variants

Structural and Functional Distinctiveness of HLA-A2 Allelic Variants

Correlating Sequence Variation with HLA‐A Allelic Families: Implications for T Cell Receptor Binding Specificities

Characterization of Hla-E Polymorphism in Four Distinct Populations in Mainland China

Epigenetic Regulation of Differential Hla-A Allelic Expression Levels

[Analysis on HLA-E Polymorphism in Guangdong Han Population].

HLA-E Monoclonal Antibodies Recognize Shared Peptide Sequences on Classical HLA Class Ia: Relevance to Human Natural HLA Antibodies

Like wings of a bird: functional divergence and complementarity between HLA-A and HLA-B molecules

The Rigidity of a Structural Bridge on HLA-I Binding Groove Explains Its Differential Outcome in Cancer Immune Response.

HLA-E Peptide Repertoire and Dimorphism—Centerpieces in the Adaptive NK Cell Puzzle?

Is HLA-E with its receptors an immune checkpoint or an antigenic determinant in allo-HCT?

HLA class I peptide polymorphisms contribute to class II DQβ0603:DQα0103 antibody specificity

Conformational and structural characteristics of peptides binding to HLA-DR molecules.

Clinical significance of HLA-E genotype and surface/soluble expression levels between healthy individuals and patients with acute leukemia

Impact of HLA-DR Antigen Binding Cleft Rigidity on T Cell Recognition

Identification and functional perspective of a novel HLA-A allele: A*0279

Improved Expression of HLA-A* 2402-BSP in Escherichia Coli and Its Tetramer Preparation

Hla Class I Alleles In Australian Aborigines And Their Peptide Binding Profiles

Natural Selection on HLA-DPB1 Amino Acids Operates Primarily on DP Serologic Categories

The antibodies 3D12 and 4D12 recognise distinct epitopes and conformations of HLA-E